FTC seeks to block Amgen's $28B Horizon buy in 'broadly negative' move for biopharma M&A: report
Fierce Pharma
MAY 16, 2023
FTC seeks to block Amgen's $28B Horizon buy in 'broadly negative' move for biopharma M&A: report aliu Tue, 05/16/2023 - 09:41
Tue.May 16, 2023
289 
Meet the Startup Promising to Deliver the 1st Healthcare-focused Generative AI Model
MedCity News
MAY 16, 2023
Hippocratic AI emerged from stealth, as well as announced $50 million in seed funding through a round co-led by General Catalyst and Andreessen Horowitz. The Palo Alto-based startup bills itself as the first large language model designed specifically for healthcare.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
AstraZeneca follows AbbVie, Teva in surprising departure from lobbying group PhRMA
Fierce Pharma
MAY 16, 2023
AstraZeneca follows AbbVie, Teva in surprising departure from lobbying group PhRMA zbecker Tue, 05/16/2023 - 11:06
How a Rural Health System Is Looking at Virtual Care and Remote Patient Monitoring
MedCity News
MAY 16, 2023
In a wide-ranging interview, Sanford Health’s president of virtual care explained how virtual care may be well suited to rural populations.
It's the end of the line for J&J's COVID shot in the US, CDC says
Fierce Pharma
MAY 16, 2023
It's the end of the line for J&J's COVID shot in the US, CDC says fkansteiner Tue, 05/16/2023 - 14:32
Zocdoc Adds Urgent Care Centers to Marketplace
MedCity News
MAY 16, 2023
Patients can now find and book urgent care appointments in 22 states at more than 200 facilities on Zocdoc’s marketplace. In 2023, the company saw the volume of new urgent care facilities on Zocdoc grow by nearly 40% month over month on average and urgent care bookings grow by 80% month over month on average.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
7 Things Employers Should Know About the End of the Covid-19 Public Health Emergency
MedCity News
MAY 16, 2023
The Covid-19 public health emergency ended May 11, which will affect employer-sponsored insurance in several ways, said Jeff Levin-Scherz, population health leader of Willis Towers Watson. This includes the coverage Covid-19 tests and vaccines.
FDA orders Sun to hire manufacturing consultant for troubled plant as export pause persists
Fierce Pharma
MAY 16, 2023
FDA orders Sun to hire manufacturing consultant for troubled plant as export pause persists fkansteiner Tue, 05/16/2023 - 09:33
FTC Files Suit to Block Amgen’s $28B Buyout of Horizon Therapeutics
MedCity News
MAY 16, 2023
The Federal Trade Commission is suing to stop Amgen’s acquisition of Horizon Therapeutics. But rather than claiming product overlap, the agency contends Amgen will use its influence to keep at bay competition for Horizon’s products.
BeiGene, Max Foundation team up to provide free Brukinsa to CLL patients in 29 low-income countries
Fierce Pharma
MAY 16, 2023
BeiGene, Max Foundation team up to provide free Brukinsa to CLL patients in 29 low-income countries aliu Tue, 05/16/2023 - 15:35
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Northwell, Aegis Ventures Launch Startup to Diagnose 140+ Diseases Via Retinal Scans
MedCity News
MAY 16, 2023
Ascertain — a healthcare AI company creation platform formed last year by Northwell Health and Aegis Ventures — has launched its first startup. New York-based Optain, which has gained an initial seed investment of $12 million, is an AI company meant to enable earlier disease detection and prevention through retinal imaging.
Moderna hits back at Alnylam's 'baseless' patent infringement claims
Fierce Pharma
MAY 16, 2023
Moderna hits back at Alnylam's 'baseless' patent infringement claims zbecker Tue, 05/16/2023 - 15:59
New Flagship Startup Metaphore Mimics Mother Nature for Drug R&D
MedCity News
MAY 16, 2023
Metaphore Biotechnologies leverages the concept of biomimicry for developing new drugs with potential applications in autoimmune diseases, metabolic disorders, and cancer. Flagship Pioneering is backing the startup with $50 million.
A Collaborative Commitment to the Sleep Community: Addressing Sleep Disorders Holistically
Fierce Pharma
MAY 16, 2023
A Collaborative Commitment to the Sleep Community: Addressing Sleep Disorders Holistically jpiatt Tue, 05/16/2023 - 10:32
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
CCC Named a Stevie® Award Winner for Customer Service Department of the Year in the 2023 American Business Awards®
Copyright Clearance Center
MAY 16, 2023
May 16, 2023 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, was named a Bronze Stevie® Award winner for Customer Service Department of the Year in the 21 st annual American Business Awards ®. The American Business Awards are the premier business awards program in the U.S. Nicknamed the “Stevies” for the Greek word meaning “crowned,” the competition receives over 12,000 entries each year from organizations in 70 countries.
Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) : Making Quality Medicines Affordable and Accessible in India
Pharmatutor
MAY 16, 2023
Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) : Making Quality Medicines Affordable and Accessible in India admin Tue, 05/16/2023 - 15:25 About Author Ramraj Choudhary M.Pharma, (Pharmaceutics) Dr. H.S Gour University, Sagar MP Current Position : Sr.
Pandemic-sized Collaboration Transforms the 3 P’s of Healthcare
MedCity News
MAY 16, 2023
As we consider the ramifications of the President’s cancellation of the Pandemic emergency, we have time to reflect on the transformation of the 3 P’s of healthcare: People, Policies and Politics.
Research consortium picks eight rare diseases to advance gene therapies
Pharmaceutical Technology
MAY 16, 2023
The Foundation for the National Institutes of Health (FNIH) has announced its plans to prioritise eight rare diseases to provide industry standards for manufacturing, preclinical testing and product analytical testing for gene therapy development. This news was announced during the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting in Los Angeles.
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
5 Attributes that Make a Great Medical Sales Manager
MedReps
MAY 16, 2023
If you’ve worked in the medical sales field long enough, you more than likely can tell the difference between a great leader and a poor one pretty quickly. Good leaders can motivate their employees, make them feel loyal and assist them when needed so they meet their goals. Bad leaders don’t measure up and their inability to lead tends to be fairly obvious upon meeting them for the first time.
AI-driven biosimilar manufacturing partnership announced
European Pharmaceutical Review
MAY 16, 2023
Sandoz and Just – Evotec Biologics have announced a partnership to develop and manufacture multiple biosimilars. Within the agreement, Sandoz will gain access to an artificial intelligence (AI) -driven technology platform that delivers fully integrated drug substance development and continuous manufacturing. This will support the expansion of Sandoz’s pipeline to 24 biosimilar assets.
Canada and the Midwest in Life Sciences, 75 Years in the Making
MedCity News
MAY 16, 2023
The Consulate General of Canada in Chicago is currently celebrating the 75th anniversary of its diplomatic presence in the Midwest.
Recent developments in stem cell therapies
European Pharmaceutical Review
MAY 16, 2023
So far, 2023 has seen several major developments in stem cell-based therapies. Stem cells have the ability to self-renew. Their potential to differentiate into cells of different tissues makes them particularly interesting for applications in regenerative medicine. 1 Since the first therapy using stem cells was developed in 1957, only few stem cell-based therapies have entered the clinic 1 as advanced therapy medicinal products (ATMPs).
Roles and Responsibilities of Specialized Clinical Supply Experts
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Robotic platform R-One+ launched by Robocath
PharmaTimes
MAY 16, 2023
Solution allows a cardiologist to perform coronary angioplasties using an integrated control command unit
Bright Path Laboratories to Collaborate in NSF Engines Development Program
PharmaTech
MAY 16, 2023
The NSF-sponsored program aims to help partners collaborate to create opportunities for significant economic, societal, and technological opportunities for growth in their regions.
Approval provided for Angelini’s cenobamate
PharmaTimes
MAY 16, 2023
Treatment will now be used across Ireland among adults with focal onset seizures with epilepsy
Increase Rep Efficiency + Effectiveness to Engage Today's Digital Buyer
Modus
MAY 16, 2023
The B2B buying environment has changed drastically over the past few years. One of the biggest changes? Buyers are bypassing sales reps altogether, and turning to self-service digital research from a variety of business sources like blogs, webinars, podcasts and peer-review sites. A study from McKinsey backs this up with findings that 70%-80% of today’s prospects prefer remote interaction or digital self-service.
Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Addressing Mental Health And Drug Addiction With Zack Cooper
Evolve Your Success
MAY 16, 2023
Drug addiction is a mental health problem, and it comes with a lot of social and psychological factors. No one just wakes up one morning and decides that they’re going to do drugs. The problem comes from somewhere else, and it’s in going to that root cause that most initiatives to tackle the drug problem fall short. This is what Zack Cooper wrestles with every day.
UniQure sells part of Hemgenix royalty rights in deal worth up to $400 million
Pharmaceutical Technology
MAY 16, 2023
UniQure is selling a part of its royalty rights to the haemophilia B gene therapy Hemgenix (etranacogene dezaparvovec) to HealthCare Royalty and Sagard Healthcare for a gross purchase price of up to $400 million dollars. This comes with an upfront cash payment of $375 million, with a potential additional $25 million if Hemgenix net sales reach a certain milestone in 2024, based on a May 15 announcement.
PM360 Announces Winners of The Ninth Annual ELITE 100 Awards
PM360
MAY 16, 2023
Press Release Contact: Andrew Matthius Senior Editor PM360 646-300-8113 NEW YORK, NY : PM360 , the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of its 9 th Annual ELITE 100. The ELITE ( E xceptional • L eaders • I nnovators • T ransformers • E ntrepreneurs) represent the most influential people and teams in the healthcare and life sciences industries based on their career accomplish
Market cap downturn hits over half of top 20 biopharmaceutical companies in Q1 2023
Pharmaceutical Technology
MAY 16, 2023
More than half of the top 20 global biopharmaceutical companies saw a fall in market capitalisation over Q1 2023. This resulted in a 3.4% decline in total aggregate market capitalisation from $3.61 trillion in Q4 2022 to $3.49 trillion in Q1 2023, according to GlobalData’s pharma intelligence centre companies database. Although 12 of the top 20 players reported negative growth in market capitalisation, eight companies saw positive growth with five companies achieving double-digit growth to more
Accelerating Clinical Supply Through Integrated Drug Development
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Let's personalize your content